1mg, best e pharmacy in India

ORGALUTRAN 0.25MG INJECTION

generic_icon
MRP: Rs. 2382 for 1 vial(s) (1 ML injection each)
1
Unfortunately, we don't have any more items in stock
Report Error

Composition for ORGALUTRAN

Ganirelix(0.25 mg)

food interaction for ORGALUTRAN

alcohol interaction for ORGALUTRAN

pregnancy interaction for ORGALUTRAN

lactation interaction for ORGALUTRAN

food
alcohol
pregnancy
lactation
It can be taken with or without food, but it is better to take Orgalutran 0.25mg injection at a fixed time.
Interaction with alcohol is unknown. Please consult your doctor.
Orgalutran 0.25mg injection is highly unsafe to use during pregnancy.
Human and animal studies have shown significant adverse effects on the foetus. Please consult your doctor.
UNSAFE
Orgalutran 0.25mg injection is probably unsafe to use during breastfeeding. Please consult your doctor.
UNSAFE

SALT INFORMATION for ORGALUTRAN

Ganirelix(0.25 mg)

Uses

Orgalutran 0.25mg injection is used in the treatment of female infertility (inability to become pregnant).

How it works

Orgalutran 0.25mg injection In females undergoing treatment for infertility sometimes premature ovulation can lead to release of eggs not ready for fertilization. Orgalutran 0.25mg injection blocks the action of a natural hormone and prevents premature release of the eggs from the ovary. In males Orgalutran 0.25mg injection works by decreasing the amount of testosterone (a male hormone) produced by the body. This may slow or stop the spread and growth of prostate cancer cells that need testosterone to grow.

Common side effects

Nausea, Ovarian hyperstimulation syndrome, Pelvic pain, Abdominal pain, Abnormal vaginal bleeding, Anaphylactic reaction, Headache, Injection site reaction

SUBSTITUTES for ORGALUTRAN

No substitutes found

Top Endocrinologists

  • Dr. Jasjeet Singh Wasir
    MBBS, MD
    4.7
  • Dr. Harmandeep Kaur
    MBBS, MD, DM
    4.5
  • Dr. Ambrish Mithal
    MBBS, MD, DM
    4.5
  • Dr. Sunil Kumar Mishra
    MBBS, MD, DM
    4.4
  • Dr. Sfurti Mann
    MBBS, MD, Diploma
    4.1

Expert advice for ORGALUTRAN

  • Make sure you are not pregnant at the time of starting this treatment. Inform your doctor if you have chances of pregnancy.
  • Ganirelix subcutaneous injection should be taken on the abdomen around the navel or upper thigh.
  • Ganirelix may cause ovarian hyperstimulation syndrome (OHSS). Seek immediate medical attention if you notice any of the symptoms (abdominal bloating, mild pain in the abdomen, weight gain).

Frequently asked questions for ORGALUTRAN

Ganirelix

Q.Is ganirelix the same as cetrotide?
Ganirelix and cetrotide are two different medicines, but both are used in women undergoing assisted reproduction techniques such as in vitro fertilization (IFV) to reduce luteinizing hormone surge

Q.Is ganirelix the same as Lupron?
No, Lupron is a brand for a different hormonal medication called gonadotropin releasing hormone agonist. Both are used in women undergoing assisted reproduction techniques such as in vitro fertilization (IFV)

Q.Is ganirelix the same as Gonal F?
No, Gonal Fis a brand name for a different hormonal medication with different usage

Q.Is ganirelix supposed to be refrigerated?
No, ganirelix should be stored at room temperature in the original package, to protect it from sunlight

Q.Is ganirelix injection painful?
Ganirelix injection can cause mild pain during administration at the injection site

Q.When is ganirelix started?
Ganirelix is started on day 5 or day 6 after FSH/corifollitropin alfa administration

Q.Does ganirelix stop follicle growth?
No, ganirelix does not slow or stop follicle growth

Q.Does ganirelix stop/ prevent ovulation?
No, ganirelix does not stop or prevent ovulation; it reduces luteinizing hormone surge in women suffering from premature ovulation or undergoing a controlled ovarian stimulation for assisted reproduction technique (like IVF) in infertility

Q.Does ganirelix make you tired?
Yes, ganirelix can make you feel tired or cause general weakness.

Articles


Content on this page was last updated on 28 September, 2016, by Dr. Varun Gupta (MD Pharmacology)